TREATMENT OF HODGKIN LYMPHOMA USING AN ANTI-PD-1 ANTIBODY

16/306,285 | U.S. Patent Application

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Location ELECTRONIC
Filed Nov. 30, 2018
Examiner DANIEL E KOLKER
Class 424
Art Group 1644
Case Type Utility - 424/142100
Status Docketed New Case - Ready for Examination
Parent PCT/US2017/035492 Published
Parent 62/344,880 Expired
Last Updated: 5 years, 3 months ago
Date # Transaction
11/8/2019Case Docketed to Examiner in GAU
9/27/2019Email Notification
9/26/2019Application ready for PDX access by participating foreign offices
9/26/2019PG-Pub Issue Notification
9/11/2019Email Notification
9/10/2019Case Docketed to Examiner in GAU
9/10/2019Email Notification
9/10/2019Notice of DO/EO Acceptance Mailed
9/10/2019Filing Receipt - Updated
9/9/2019Application Is Now Complete
9/9/2019Application Dispatched from OIPE
9/9/2019FITF set to YES - revise initial setting
8/20/2019Information Disclosure Statement (IDS) Filed
8/20/2019Additional Application Filing Fees
8/20/2019Preliminary Amendments
8/20/2019Information Disclosure Statement (IDS) Filed
6/20/2019Electronic Review
6/20/2019Email Notification
6/20/2019Email Notification
6/20/2019Filing Receipt
6/20/2019371 Supplemental Fees Missing - Form M923
12/2/2018371 Completion Date
11/30/2018Request for Foreign Priority (Priority Papers May Be Included)
11/30/2018Patent Term Adjustment - Ready for Examination
11/30/2018Copy of the International Application
11/30/2018PTO/SB/69-Authorize EPO Access to Search Results
11/30/2018Applicants have given acceptable permission for participating foreign
11/30/2018Cleared by OIPE CSR
11/30/2018ENTITY STATUS SET TO UNDISCOUNTED (INITIAL DEFAULT SETTING OR STATUS CHANGE)
11/30/2018Initial Exam Team nn